COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,746,764 | -62.9% | 78,155 | -60.1% | 0.01% | -55.2% |
Q1 2023 | $4,704,343 | +347.6% | 196,096 | +199.0% | 0.03% | +383.3% |
Q3 2022 | $1,051,000 | -31.1% | 65,578 | -12.4% | 0.01% | -53.8% |
Q1 2022 | $1,525,000 | +177.3% | 74,897 | +154.5% | 0.01% | +160.0% |
Q4 2021 | $550,000 | -32.2% | 29,427 | -28.4% | 0.01% | -50.0% |
Q3 2021 | $811,000 | -29.6% | 41,105 | -15.6% | 0.01% | -23.1% |
Q2 2021 | $1,152,000 | -12.5% | 48,725 | -12.2% | 0.01% | -23.5% |
Q1 2021 | $1,316,000 | +194.4% | 55,521 | +149.0% | 0.02% | +183.3% |
Q4 2020 | $447,000 | -34.2% | 22,299 | -31.6% | 0.01% | -40.0% |
Q3 2020 | $679,000 | +21.9% | 32,594 | +2.3% | 0.01% | 0.0% |
Q2 2020 | $557,000 | -50.7% | 31,852 | -53.9% | 0.01% | -67.7% |
Q1 2020 | $1,129,000 | +75.6% | 69,121 | +121.3% | 0.03% | +158.3% |
Q4 2019 | $643,000 | +27.8% | 31,237 | -6.0% | 0.01% | -25.0% |
Q1 2019 | $503,000 | +230.9% | 33,248 | +222.5% | 0.02% | +100.0% |
Q3 2018 | $152,000 | -28.6% | 10,309 | +15.5% | 0.01% | -27.3% |
Q2 2018 | $213,000 | – | 8,926 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $48,689,000 | 2.30% |
Camber Capital Management LP | 1,050,000 | $19,614,000 | 0.67% |
OneAscent Wealth Management LLC | 14,131 | $264,000 | 0.66% |
Eventide Asset Management | 2,629,593 | $49,121,000 | 0.63% |
CLARK ESTATES INC/NY | 183,800 | $3,433,000 | 0.50% |
Values First Advisors, Inc. | 42,312 | $790,000 | 0.47% |
RICE HALL JAMES & ASSOCIATES, LLC | 704,201 | $13,154,000 | 0.47% |
EMERALD MUTUAL FUND ADVISERS TRUST | 650,398 | $12,149,000 | 0.43% |
OneAscent Financial Services LLC | 11,774 | $220,000 | 0.42% |
Factorial Partners, LLC | 33,300 | $622,000 | 0.41% |